5.44 - 5.64
4.95 - 8.28
2.1K / 2.4K (Avg.)
-272.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.40%
Revenue growth under 50% of VALMT.HE's 40.26%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-0.13%
Negative gross profit growth while VALMT.HE is at 31.25%. Joel Greenblatt would examine cost competitiveness or demand decline.
3.20%
EBIT growth below 50% of VALMT.HE's 70.89%. Michael Burry would suspect deeper competitive or cost structure issues.
3.20%
Operating income growth under 50% of VALMT.HE's 70.89%. Michael Burry would be concerned about deeper cost or sales issues.
4.89%
Net income growth under 50% of VALMT.HE's 75.44%. Michael Burry would suspect the firm is falling well behind a key competitor.
7.69%
EPS growth under 50% of VALMT.HE's 76.32%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
7.69%
Diluted EPS growth under 50% of VALMT.HE's 76.32%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-2.60%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-2.60%
Reduced diluted shares while VALMT.HE is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
8.87%
OCF growth under 50% of VALMT.HE's 21.28%. Michael Burry might suspect questionable revenue recognition or rising costs.
30.49%
FCF growth 1.25-1.5x VALMT.HE's 23.29%. Bruce Berkowitz would see if capex decisions or cost controls create a cash flow advantage.
-34.34%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 25.76%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-2.62%
Negative 5Y CAGR while VALMT.HE stands at 36.83%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
6.36%
3Y revenue/share CAGR under 50% of VALMT.HE's 23.51%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
515.31%
10Y OCF/share CAGR above 1.5x VALMT.HE's 240.30%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
16.93%
Below 50% of VALMT.HE's 78.57%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-22.54%
Negative 3Y OCF/share CAGR while VALMT.HE stands at 28.20%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
306.82%
Below 50% of VALMT.HE's 1561.39%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
76.98%
Below 50% of VALMT.HE's 271.29%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
18.81%
Below 50% of VALMT.HE's 115.13%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
28.48%
Below 50% of VALMT.HE's 172.45%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
27.95%
5Y equity/share CAGR at 75-90% of VALMT.HE's 33.31%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
20.26%
3Y equity/share CAGR similar to VALMT.HE's 21.25%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.55%
Firm’s AR is declining while VALMT.HE shows 23.69%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-2.82%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
3.16%
Asset growth well under 50% of VALMT.HE's 7.52%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
8.29%
50-75% of VALMT.HE's 12.00%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-2.13%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
15.04%
We expand SG&A while VALMT.HE cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.